262 related articles for article (PubMed ID: 27578919)
21. High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive Chemoradiotherapy.
Mitra D; Horick NK; Brackett DG; Mouw KW; Hornick JL; Ferrone S; Hong TS; Mamon H; Clark JW; Parikh AR; Allen JN; Ryan DP; Ting DT; Deshpande V; Wo JY
Oncologist; 2019 Jun; 24(6):e275-e283. PubMed ID: 30755500
[TBL] [Abstract][Full Text] [Related]
22. Indoleamine-2,3-dioxygenase-1 expression predicts poorer survival and up-regulates ZEB2 expression in human early stage bladder cancer.
Tsai YS; Jou YC; Tsai HT; Cheong IS; Tzai TS
Urol Oncol; 2019 Nov; 37(11):810.e17-810.e27. PubMed ID: 31253481
[TBL] [Abstract][Full Text] [Related]
23. Tryptophan 2,3-Dioxygenase Expression Identified in Murine Decidual Stromal Cells Is Not Essential for Feto-Maternal Tolerance.
Hoffmann D; Dvorakova T; Schramme F; Stroobant V; Van den Eynde BJ
Front Immunol; 2020; 11():601759. PubMed ID: 33363543
[TBL] [Abstract][Full Text] [Related]
24. IDO1 and Kynurenine Pathway Metabolites Activate PI3K-Akt Signaling in the Neoplastic Colon Epithelium to Promote Cancer Cell Proliferation and Inhibit Apoptosis.
Bishnupuri KS; Alvarado DM; Khouri AN; Shabsovich M; Chen B; Dieckgraefe BK; Ciorba MA
Cancer Res; 2019 Mar; 79(6):1138-1150. PubMed ID: 30679179
[TBL] [Abstract][Full Text] [Related]
25. IDO1 metabolites activate β-catenin signaling to promote cancer cell proliferation and colon tumorigenesis in mice.
Thaker AI; Rao MS; Bishnupuri KS; Kerr TA; Foster L; Marinshaw JM; Newberry RD; Stenson WF; Ciorba MA
Gastroenterology; 2013 Aug; 145(2):416-25.e1-4. PubMed ID: 23669411
[TBL] [Abstract][Full Text] [Related]
26. Constitutive Expression of the Immunosuppressive Tryptophan Dioxygenase TDO2 in Glioblastoma Is Driven by the Transcription Factor C/EBPβ.
Kudo T; Prentzell MT; Mohapatra SR; Sahm F; Zhao Z; Grummt I; Wick W; Opitz CA; Platten M; Green EW
Front Immunol; 2020; 11():657. PubMed ID: 32477324
[TBL] [Abstract][Full Text] [Related]
27. Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening.
Guo W; Yao S; Sun P; Yang TB; Tang CP; Zheng MY; Ye Y; Meng LH
Acta Pharmacol Sin; 2020 Mar; 41(3):423-431. PubMed ID: 31197246
[TBL] [Abstract][Full Text] [Related]
28. In silico discovery and therapeutic potential of IDO1 and TDO2 inhibitors.
Jernigan FE; Sun L
Future Med Chem; 2017 Aug; 9(12):1309-1311. PubMed ID: 28771034
[No Abstract] [Full Text] [Related]
29. The Tobacco β-Cembrenediol: A Prostate Cancer Recurrence Suppressor Lead and Prospective Scaffold via Modulation of Indoleamine 2,3-Dioxygenase and Tryptophan Dioxygenase.
Mudhish EA; Siddique AB; Ebrahim HY; Abdelwahed KS; King JA; El Sayed KA
Nutrients; 2022 Apr; 14(7):. PubMed ID: 35406118
[TBL] [Abstract][Full Text] [Related]
30. Gene expression of indoleamine and tryptophan dioxygenases and three long non-coding RNAs in breast cancer.
Ghafouri-Fard S; Taherian-Esfahani Z; Dashti S; Kholghi Oskooei V; Taheri M; Samsami M
Exp Mol Pathol; 2020 Jun; 114():104415. PubMed ID: 32165090
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of novel tryptanthrin derivatives as dual inhibitors of indoleamine 2,3-dioxygenase 1 and tryptophan 2,3-dioxygenase.
Li Y; Zhang S; Wang R; Cui M; Liu W; Yang Q; Kuang C
Bioorg Med Chem Lett; 2020 Jun; 30(11):127159. PubMed ID: 32247733
[TBL] [Abstract][Full Text] [Related]
32. Indoleamine dioxygenase and tryptophan dioxygenase activities are regulated through control of cell heme allocation by nitric oxide.
Biswas P; Stuehr DJ
J Biol Chem; 2023 Jun; 299(6):104753. PubMed ID: 37116709
[TBL] [Abstract][Full Text] [Related]
33. Extensive profiling of the expression of the indoleamine 2,3-dioxygenase 1 protein in normal and tumoral human tissues.
Théate I; van Baren N; Pilotte L; Moulin P; Larrieu P; Renauld JC; Hervé C; Gutierrez-Roelens I; Marbaix E; Sempoux C; Van den Eynde BJ
Cancer Immunol Res; 2015 Feb; 3(2):161-72. PubMed ID: 25271151
[TBL] [Abstract][Full Text] [Related]
34. Indoleamine 2,3-dioxygenase 1 and programmed cell death-ligand 1 co-expression correlates with aggressive features in lung adenocarcinoma.
Kozuma Y; Takada K; Toyokawa G; Kohashi K; Shimokawa M; Hirai F; Tagawa T; Okamoto T; Oda Y; Maehara Y
Eur J Cancer; 2018 Sep; 101():20-29. PubMed ID: 30014971
[TBL] [Abstract][Full Text] [Related]
35.
Yang D; Zhang S; Fang X; Guo L; Hu N; Guo Z; Li X; Yang S; He JC; Kuang C; Yang Q
J Med Chem; 2019 Oct; 62(20):9161-9174. PubMed ID: 31580660
[TBL] [Abstract][Full Text] [Related]
36. Impact of sidedness of colorectal cancer on tumor immunity.
Takasu C; Nishi M; Yoshikawa K; Tokunaga T; Kashihara H; Yoshimoto T; Shimada M
PLoS One; 2020; 15(10):e0240408. PubMed ID: 33045001
[TBL] [Abstract][Full Text] [Related]
37. Mechanism and prognostic value of indoleamine 2,3-dioxygenase 1 expressed in hepatocellular carcinoma.
Li S; Han X; Lyu N; Xie Q; Deng H; Mu L; Pan T; Huang X; Wang X; Shi Y; Zhao M
Cancer Sci; 2018 Dec; 109(12):3726-3736. PubMed ID: 30264546
[TBL] [Abstract][Full Text] [Related]
38. Discovery and structure-activity relationship studies of 1-aryl-1H-naphtho[2,3-d][1,2,3]triazole-4,9-dione derivatives as potent dual inhibitors of indoleamine 2,3-dioxygenase 1 (IDO1) and trytophan 2,3-dioxygenase (TDO).
Pan S; Zhou Y; Wang Q; Wang Y; Tian C; Wang T; Huang L; Nan J; Li L; Yang S
Eur J Med Chem; 2020 Dec; 207():112703. PubMed ID: 32871341
[TBL] [Abstract][Full Text] [Related]
39. Characterization and evolution of vertebrate indoleamine 2, 3-dioxygenases IDOs from monotremes and marsupials.
Yuasa HJ; Ball HJ; Ho YF; Austin CJ; Whittington CM; Belov K; Maghzal GJ; Jermiin LS; Hunt NH
Comp Biochem Physiol B Biochem Mol Biol; 2009 Jun; 153(2):137-44. PubMed ID: 19402226
[TBL] [Abstract][Full Text] [Related]
40. The Clinicopathological and Prognostic Significance of IDO1 Expression in Human Solid Tumors: Evidence from a Systematic Review and Meta-Analysis.
Yu CP; Fu SF; Chen X; Ye J; Ye Y; Kong LD; Zhu Z
Cell Physiol Biochem; 2018; 49(1):134-143. PubMed ID: 30134237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
